The quantitative and qualitative expression of the extracellular matrix (ECM) is paramount for cardiac function 1 . In close relation with the cellular compartment, the components of the extracellular matrix are critical for transmitting information from the extracellular medium to cardiomyocytes 2 . The interaction between the cellular compartment and the cardiac interstitium occurs in response to the physiological stimuli of normal development and in overload conditions, when the disproportional growth of the cellular and extracellular components is the basis for the ventricular dysfunction seen in pathological myocardial hypertrophy [3] [4] [5] [6] . One of the key elements in understanding this heterogeneous pattern of growth and its deleterious effects on cardiac function is the quantitative and qualitative alteration in the collagen matrix. In fact, the interstitial fibrosis, by determining alterations in the myocardial physical structure, adversely affects ventricular function even when the hypertrophied cardiomyocytes still preserve the capacity of contraction 5,7 . The type I and III collagens produced by fibroblasts are the major components of the myocardial collagen matrix 8 , whose development is regulated by several growth factors. Some studies have pointed out angiotensin II as a mediator of the growth of the collagen matrix that can induce the proliferation of fibroblasts and the increase in the collagen synthesis by fibroblasts [9] [10] [11] . Recently, AT1 and AT2 receptors for angiotensin II were identified in the fetal cardiac tissue drawing attention to the possibility that that hormone may regulate the expression of the myocardial collagen matrix from the earliest stages of cardiac embryonic formation [12] [13] [14] . This study was designed to test the hypothesis that the inhibition of the angiotensin-converting enzyme (ACE) during the gestational period can interfere with myocardial morphogenesis by attenuating the content of the collagen matrix.
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Methods
This study abided by the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (publication n° 85-23, revised in 1985). We studied newborn rats generated from spontaneously hypertensive female rats (SHR) maintained in the vivarium of the laboratory of cardiovascular morphometry and morphology of the Instituto de Biologia Roberto Alcântara Gomes of the Universidade do Estado de Rio de Janeiro (IBRAG/UERJ). The pregnant females were maintained in polypropylene cages under controlled temperature (21±1°C) and humidity (60±10%) conditions, with day-night cycles of 12 hours (with artificial illumination), and air exhaust (15 min/h). The newborn animals were divided into 2 groups (n=5 in each) as follows: treated group -females treated with enalapril maleate (15 mg.kg -1 .day -1 ) dissolved into drinking water, initiated during the mating period and maintained until the birth day; and the nontreated group. The newborns were analyzed (measurement of body and cardiac masses with a 0.001g-precision scale) and euthanized within the first 24 hours of life by decapitation.
The hearts were removed, immediately fixed by immersion in a Bouin solution for 48 hours at room temperature, and processed for inclusion in Paraplast plus ® (Sigma Co., St Louis). Three mm-thick sections were stained with PicroSirius red to be studied with light microscopy. The slides were analyzed (3 fields per animal) on a Leica DMRBE  microscope coupled with a Kappa  camera under polarized light, and the images were digitalized for computer-assisted analysis. The images captured were semi-automatically segmented to determine the volume densities of nuclei (V v nucleus) and collagen matrix (V v matrix) with the aid of Image Pro Plus 4.5.029 software (Media Cybernetics).
The biometric differences of the newborns were tested with the Student t test (nonpaired). The stereological data were analyzed with the nonparametric Kolmogorov-Smirnov test. The statistical significance level of 0.05 was adopted 15 .
Results
The results are shown in table I and figures 1 to 3. No difference was found between the treated and nontreated groups in regard to body mass, cardiac mass, and the relation between cardiac and body masses. A significant reduction in V v [matrix] and a concomitant increase in V v [nuclei] were observed in the treated group as compared with those in the nontreated group ( figs. 1 and 2) . The study of the collagen matrix with light microscopy stressed the differences between the groups of SHRs mainly with the use of polarized light, which showed a greater amount of collagen fibers in the newborns of the nontreated group ( fig. 3 ).
Discussion
Angiotensin II plays an important role in the regulation of myocardial remodeling in response to overload conditions, such as in hypertensive disease of the heart and in the remaining portions of the heart suffering an acute myocardial infarction 16 . In hypertrophied hearts, although the cardiomyocytes preserve their capacity for contraction, the myocardium frequently exhibits striking functional Table I 17 . This apparent paradox is understood when analyzed considering the alterations observed in the structure of the myocardial interstitium. The concentration and organization of the components of the collagen matrix influence the physical characteristics of the cardiovascular tissue. The development of heart failure in arterial hypertension is related to the myocardial fibrosis in experimental animal models and in studies with human beings 18 . The composition of the collagen matrix also affects the way the cells perceive the forces applied to the tissue. Myocardial stiffness influences the degree of deformation of the matrix in response to a mechanical stimulus; the cellular alignment determined by the matrix defines which cell portions will be exposed to the force. Through the cytoskeleton, all cells, not only the cardiomyocytes and smooth muscle cells, can generate tension 19 . At least 5 types of collagen were found in the heart. The most abundant are types I and III, which together represent approximately 90% of cardiac collagen. The fibroblasts are the cells responsible for the synthesis and breakdown of collagen. Collagen has a high proportion of hydroxyproline, an amino acid present in low concentrations in a very limited number of other proteins. The content of tissue collagen may be assessed through the measurement of the content of hydroxyproline 3 . Because they have diverse physical characteristics, the relative proportion of collagen types I and III influences the properties of the myocardial tissue. Type I collagen forms thick fibers, which are highly resistant to tension, while type III collagen, more flexible, forms a thin net of fibrils. Together, both types are responsible for the structure and distensibility of the normal heart 4 . Three other types of collagen were observed in the heart. Types IV and V are constituents of the basement membrane. Type IV collagen was implicated in the regulation of angiogenesis as a constituent of the basement membrane of neoformed vessels 20 . Type VI is encountered in the interstitium together with other fibrillary collagens and plays a role in the regulation of the size of the fiber.
-Body mass (BM) and cardiac mass (CA) of treated (T) and untreated (UT) SHR. NS indicate non-siginificant, p is the probability of the difference to be different from zero (Student nonpaired t test).

Dates
The renin-angiotensin-aldosterone system has been recognized as a key element in the events culminating with the development of myocardial fibrosis. Angiotensin II can stimulate the synthesis of collagen by fibroblasts through type AT1 receptors. Angiotensin II also inhibits the in vitro activity of collagenase 5 . Its action on fibroblasts seems to be modulated by calcium. The administration of angiotensin II increases the concentration of intracellular calcium in fibroblasts, an effect partially modulated by insulin 21 . The myocardial fibrosis induced by angiotensin II and aldosterone was shown to be attenuated by the concomitant administration of mibefradil, a calcium channel blocker 22 . The positive impact of the pharmacological intervention on myocardial remodeling has been shown in clinical studies with the use of angiotensin-converting enzyme inhibitors in human beings experiencing acute myocardial infarction 23, 24 and in experimental essays with different models of hypertension. A recent clinical study assessing the effect of lisinopril in hypertensive patients with the echocardiographic diagnosis of left ventricular hypertrophy evidenced on biopsy reported that the drug could cause regression of preexisting fibrosis 25 . Similarly, the use of angiotensin-converting enzyme inhibitors in SHR resulted in attenuation and even regression of perivascular and interstitial fibrosis 26 . The recognition of the action of angiotensin II in the genesis of the fibrosis that accompanies pathological myocardial hypertrophies indicates the possibility that this hormone may also be involved in the regulation of the physiological hypertrophy of myocardial growth and of the em bryonic development of the interstitial matrix. Recent studies have shown that AT1 and AT2 receptors for angiotensin II are expressed very early in fetal cardiac tissue. The high density of the receptors for angiotensin II in the embryonic myocardium has been interpreted as evidence that angiotensin II plays a regulator role in collagen expression during fetal development 27 . This function attributed to angiotensin II has been confirmed by experiments with rats treated with angiotensin-converting enzyme inhibitors during gestation, which resulted in abnormalities in the forma- 
